CN103071046B - Medicine paste for treating high myopia macular hemorrhage - Google Patents
Medicine paste for treating high myopia macular hemorrhage Download PDFInfo
- Publication number
- CN103071046B CN103071046B CN201310037297.4A CN201310037297A CN103071046B CN 103071046 B CN103071046 B CN 103071046B CN 201310037297 A CN201310037297 A CN 201310037297A CN 103071046 B CN103071046 B CN 103071046B
- Authority
- CN
- China
- Prior art keywords
- grams
- medicine
- high myopia
- paste
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The invention discloses a medicine paste for treating high myopia macular hemorrhage. A medicine of the paste is prepared from the following components: 30 g of radix sanguisorbae, 50 g of rhizoma polygonati, 75 g of amoorcorn tree bark, 40 g of lysimachia christinae hance, 75 g of houttuynia cordata, 50 g of radix isatidis, 60 g of mulberry fruit, 75 g of gardenia, 200 g of Chinese lobelia, 150 g of radix scrophularise, 60 g of salvia chinensis, 50 g of fructus crataegi and 30 g of white mulberry root-bark. The paste is prepared by mixing the components uniformly and smashing into coarse powder. When in use, the paste is pasted at a temple, and has an obvious treatment effect on the high myopia macular hemorrhage.
Description
Technical field the invention belongs to technical field of Chinese medicines, relates to treatment macular hemorrhage in high myopia medicine patch, the Chinese patent medicine of preparing take Chinese herbal medicine as raw material specifically.
Background technology high myopia is one of commonly encountered diseases having a strong impact on visual function, it is the important complication of high myopia that near degeneration high myopia macula area and macula lutea changes, especially punctum luteum hemorrhage is the main cause that causes permanent low vision or blinding, current this disease of western medical treatment is take troxerutin, hyaluronate sodium as main, but poor effect.Chinese medicine is huge potentiality tool for aspect this disease for the treatment of, and therefore invention is treated macular hemorrhage in high myopia medicine patch and treated this disease.
Summary of the invention the object of this invention is to provide treatment macular hemorrhage in high myopia medicine patch, to overcome the deficiencies in the prior art.
The object of the invention is pathogenetic understanding and Therapeutic Principle thereof to macular hemorrhage in high myopia according to motherland's medical tradition medical science, with reference to modern pharmacological research, therefrom filter out this sick natural Chinese medicinal herb for the treatment of, by theory of Chinese medical science prescription, it is played a role.
The medicine of patch of the present invention is made up of following component:
30 grams of 50 grams of Cortex Mori of 200 grams of Radix Scrophulariaes of 75 grams of Herba Lobeliae Chinensis of 60 grams of Fructus Gardeniaes of 50 grams of Fructus Moris of 75 grams of Radix Isatidis of 40 grams of Herba Houttuyniae of 75 grams of Herba Lysimachiaes of 50 grams of Cortex Phellodendris of 30 grams of Rhizoma Polygonatis of Radix Sanguisorbae, 150 grams of Herba Salviae Chinensiss, 60 Keshan short, bristly hair or beard
Above-mentioned each component mix homogeneously is ground into coarse powder, makes the fluid extract of relative density approximately 1.05 with 90% ethanol, add in addition the substrate that 3-4 times of weight is made up of rubber, Colophonium etc., make coating, be coated with cream, cutting, lid lining, is cut into long 3 centimetres, wide 3 centimetres of patch sheets, obtains patch of the present invention.Using method: be affixed in the temporal outer skin of patient, change once every day.
Medicine patch of the present invention is Chinese medicine preparation, theoretical according to traditional Chinese medical science formula, select medicine rationally, treating both the principal and secondary aspects of a disease.Through clinical observation patient for many years, evident in efficacy, patch absorbing transmission from skin medicine of the present invention and act on relevant acupuncture point and bring into play through sick effect, remarkable result.It is raw material that the present invention selects natural plant, and each component meets pharmaceutical control law regulation, utilizes the comprehensive function treatment macular hemorrhage in high myopia of each taste medicine, nontoxic to human body, has no side effect, safe and reliable; The present invention is patch, and effective ingredient scatters and disappears few, and curative effect is high, cheap, and taking convenience, without any discomfort disease; Medicine patch of the present invention is obvious to macular hemorrhage in high myopia curative effect; Clinical drug of the present invention is observed, and can replace the method for other treatment macular hemorrhage in high myopia.
For showing the therapeutic effect of medicine of the present invention to macular hemorrhage in high myopia, the present invention is through the clinical observation of 100 routine macular hemorrhage in high myopia systems, and select medical history, the state of an illness, age and macular hemorrhage in high myopia patient 86 examples suitable with traditional therapy as a control group, age 16-62 year, course of disease 1-6; Test group: the conventional medicine of stopping using, uses medicine of the present invention; Matched group: use conventional medicine.Observation period is 3 months, check after 3 months, and it is clear for curing that punctum luteum hemorrhage disappears, looks thing completely.Punctum luteum hemorrhage is most of to be absorbed, corrects defects of vision and improve more than 2 row as effective; Punctum luteum hemorrhage partially absorbs, corrects defects of vision and improves 1-2 behavior and take a turn for the better; After treatment, punctum luteum hemorrhage is invalid without absorbing, correct defects of vision without rising to.
Clinical comparison the results are shown in Table 1.
Table 1: use medicine patch of the present invention and the observation of curative effect that uses conventional medicine to macular hemorrhage in high myopia patient.
Two groups of curative effect comparisons of table 1 (example, %)
| Group | n | Recovery from illness | Effective | Take a turn for the better | Invalid | Total significant figure |
| Experimental group | 100 | 60(60) | 30(30) | 9(9) | 1(1) | 99(99) |
| Matched group | 86 | 38(44.2) | 18(20.9) | 14(16.3) | 16(18.6) | 70(81.4) |
Note: curative effect relatively adopts statistical method, enumeration data adopts X
2check, two groups of relatively P < 0.01 of effective percentage
As can be seen from Table 1, patch of the present invention is to 100 routine macular hemorrhage in high myopia patients, recovery from illness have 60 examples, account for 60%, have 30 examples of remarkable result, account for 30%, improvement have 9 examples, account for 9%; Total effective rate reaches 99%.Use medicine patch treatment macular hemorrhage in high myopia of the present invention than using conventional medicament to have the superiority of significance.
The specific embodiment
Choose raw material by following proportioning:
30 grams of 50 grams of Cortex Mori of 200 grams of Radix Scrophulariaes of 75 grams of Herba Lobeliae Chinensis of 60 grams of Fructus Gardeniaes of 50 grams of Fructus Moris of 75 grams of Radix Isatidis of 40 grams of Herba Houttuyniae of 75 grams of Herba Lysimachiaes of 50 grams of Cortex Phellodendris of 30 grams of Rhizoma Polygonatis of Radix Sanguisorbae, 150 grams of Herba Salviae Chinensiss, 60 Keshan short, bristly hair or beard
Above-mentioned each component mix homogeneously is ground into coarse powder, makes the fluid extract of relative density approximately 1.05 with 90% ethanol, add in addition the substrate that 3-4 times of weight is made up of rubber, Colophonium etc., make coating, be coated with cream, cutting, lid lining, is cut into long 3 centimetres, wide 3 centimetres of patch sheets, obtains patch of the present invention.
Claims (1)
1. the medicine patch for the treatment of macular hemorrhage in high myopia, is characterized in that it is the patch of being made up of the raw material of following weight proportioning: 30 grams of Radix Sanguisorbaes, 50 grams of Rhizoma Polygonatis, 75 grams of Cortex Phellodendris, 40 grams of Herba Lysimachiaes, 75 grams of Herba Houttuyniae, 50 grams of Radix Isatidis, 60 grams, Fructus Mori, 75 grams of Fructus Gardeniaes, 200 grams of Herba Lobeliae Chinensis, 150 grams of Radix Scrophulariaes, 60 grams of Herba Salviae Chinensiss, 50 grams of Fructus Crataegis, 30 grams of Cortex Mori; Above-mentioned each component drug mix homogeneously is ground into coarse powder to be made patch and get final product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310037297.4A CN103071046B (en) | 2013-01-22 | 2013-01-22 | Medicine paste for treating high myopia macular hemorrhage |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310037297.4A CN103071046B (en) | 2013-01-22 | 2013-01-22 | Medicine paste for treating high myopia macular hemorrhage |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103071046A CN103071046A (en) | 2013-05-01 |
| CN103071046B true CN103071046B (en) | 2014-06-04 |
Family
ID=48147891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310037297.4A Expired - Fee Related CN103071046B (en) | 2013-01-22 | 2013-01-22 | Medicine paste for treating high myopia macular hemorrhage |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103071046B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104587094A (en) * | 2015-02-11 | 2015-05-06 | 陈红 | Pharmaceutical composition for treating macular hemorrhage in high myopia and application of pharmaceutical composition |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1153653A (en) * | 1996-10-17 | 1997-07-09 | 成都中医药大学附属医院 | Oral Danhong liquid for dispersing blood clots and its prepn process |
| CN1772261A (en) * | 2005-11-11 | 2006-05-17 | 何伟 | Oral medicine for treafing eye inflammation, lession and hemorrhage and its prepn |
| CN102106977A (en) * | 2009-12-24 | 2011-06-29 | 孟繁英 | Externally-applied sturdy vision eyeshield liquid medicine for preventing and treating oculopathy |
-
2013
- 2013-01-22 CN CN201310037297.4A patent/CN103071046B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1153653A (en) * | 1996-10-17 | 1997-07-09 | 成都中医药大学附属医院 | Oral Danhong liquid for dispersing blood clots and its prepn process |
| CN1772261A (en) * | 2005-11-11 | 2006-05-17 | 何伟 | Oral medicine for treafing eye inflammation, lession and hemorrhage and its prepn |
| CN102106977A (en) * | 2009-12-24 | 2011-06-29 | 孟繁英 | Externally-applied sturdy vision eyeshield liquid medicine for preventing and treating oculopathy |
Non-Patent Citations (2)
| Title |
|---|
| 眼科常用中药杂记;谷万章;《航空航天医药》;20041231;第15卷(第03期);185－187 * |
| 谷万章.眼科常用中药杂记.《航空航天医药》.2004,第15卷(第03期),185－187. |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103071046A (en) | 2013-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103100075B (en) | Medicament for treating eczema | |
| CN102406698B (en) | External medicinal liquid for treating vitiligo | |
| CN102743645B (en) | Chinese medicinal preparation for treating premature ejaculation | |
| CN102430071A (en) | Medicament for treating herpes zoster | |
| CN103505643B (en) | Medicament for treating postpartum urinary retention | |
| CN101954042A (en) | Tumor eliminating capsule | |
| CN103071046B (en) | Medicine paste for treating high myopia macular hemorrhage | |
| CN101843861B (en) | Chinese medicinal composition for treating tonsillitis | |
| CN104491684A (en) | Traditional Chinese medicine for treating insomnia and application thereof | |
| CN107375613A (en) | A kind of Chinese medical extract and its external preparation that red blood trace on face effect is removed with Eradicates | |
| CN107362244A (en) | A kind of Eradicates removes the Chinese medical extract and its external preparation of red blood trace on face | |
| CN102600359B (en) | Patch for treating abdominal wall endometriosis after cesarean section | |
| CN103070992B (en) | Medicine for treating high myopia macular hemorrhages | |
| CN104083469B (en) | A kind of Chinese medicine being used for the treatment of Senile Functional Constipation | |
| CN102552503B (en) | Traditional Chinese medicine powder used for treating cervical erosion | |
| CN102552570B (en) | Medicine for treating acra necrosis after bone trauma | |
| CN102614373A (en) | Patch for treating aortic arch syndrome | |
| CN103656379A (en) | Medicinal patch for treating superficial vein embolism | |
| CN105456449A (en) | Traditional Chinese medicine for treating liver-yang excess type transient ischemic attacks and preparation method | |
| CN104825809A (en) | Medicament for treating peripheral facial paralysis | |
| CN103933296A (en) | Traditional Chinese medicine for treating chromic glomerulonephritis | |
| CN103463611A (en) | Traditional Chinese medicine composite for treating seborrhoeic alopecia and preparing method thereof | |
| CN103655875B (en) | Treatment blood sampling causes the medicine of Patients with Aplastic Anemia venous thrombosis | |
| CN103071052B (en) | Medicine for treating evaporative dry eyes | |
| CN103285289A (en) | Traditional Chinese medicine for treating arthralgia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140604 Termination date: 20150122 |
|
| EXPY | Termination of patent right or utility model |